GP(HK) Enters into A Few Agreements in the Field of Cancer Diagnostics and Treatment Introduce Multiple RDC and Strengthen Strategic Planning and Innovation in Anti-tumor Field 2020-11-1 Corporate News READ MORE
Four Products of GP (HK) that Obtained Consistency Evaluation Approvals, Namely Sodium Bicarbonate Tablets, Trimetazidine Tablets, Finasteride Tablets and Captopril Tablets, Have Successfully Won the Bids in the Third Batch of National Centralized Drug Procurement 2020-8-20 Corporate News READ MORE
GP (HK) Announces 2020 Interim Results Profit Attributable to Owners of the Company Rapidly Increases 31.4% to HK$718.5 million With A Focus on Global Expansion and Self-Development Seven Investment, M&A and Cooperation Projects Progress Steadily 2020-8-10 Corporate News READ MORE
GP (HK) Enters into a Capital Subscription and Acquisition Agreement, Acquires the Third-Generation Stent Retriever Contributing to Achieve the Strategic Plan of “Treating the Heart and Brain with the Same Therapeutic Method”, Enhancing Global “Precision Diagnostics + Treatment” Planning 2020-7-28 Corporate News READ MORE
GP (HK) Enters into an Investment Agreement with Revolmmune Introducing the World-Wide Innovative VSV-GPM To Strengthen the Strategic Planning in Tumor Precision Treatment and Tumor Immunotherapy 2020-7-15 Corporate News READ MORE
GP (HK) Enters into an Investment Agreement with eTheRNA Introducing the mRNA Vaccine Platform To Enrich Product Pipeline and Extend the Reach in Multiple Therapeutic Areas 2020-5-31 Corporate News READ MORE
GP (HK) Announces 2019 Annual Report Three Core Competitiveness Strengthens its Path to an International Pharm Company 2020-5-15 Corporate News READ MORE
GP (HK)’s World-wide Innovative Drug STC3141 Got Approval for Phase II Clinical Research on COVID-19 ARDS and Phase IB Clinical Research on Sepsis, High-quality Product Contributes to Global Epidemic Prevention & Control 2020-5-7 Corporate News READ MORE
GP (HK) Obtains Medical Device Registration Certificate for the First Drug Coated Balloon Specified for Vascular Access for Hemodialysis in the PRC Market 2020-4-21 Corporate News READ MORE
English
